PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
This Quarter Return
-4.23%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$54M
AUM Growth
+$54M
(-9.5%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-4.85%
Top 10 Holdings %
Top 10 Hldgs %
39.51%
Holding
94
New
24
Increased
13
Reduced
28
Closed
20
Top Buys
| 1 |
AbbVie
ABBV
|
$2.63M |
| 2 |
HCA Healthcare
HCA
|
$2.51M |
| 3 |
Apple
AAPL
|
$2.05M |
| 4 |
Elevance Health
ELV
|
$1.57M |
| 5 |
Gilead Sciences
GILD
|
$1.51M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$2.49M |
| 2 |
AerCap
AER
|
$2.11M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$1.73M |
| 4 |
Charles Schwab
SCHW
|
$1.53M |
| 5 |
Alibaba
BABA
|
$1.17M |
Sector Composition
| 1 | Healthcare | 54.29% |
| 2 | Technology | 14.39% |
| 3 | Financials | 7.87% |
| 4 | Communication Services | 6.89% |
| 5 | Consumer Discretionary | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Meta Platforms (Facebook)
META
$1.83T
| $676K | 1.1% |
5,927
-2,845
| -32% | -$324K |
|
27
Netflix
NFLX
$511B
| $654K | 1.07% |
6,399
-747
| -10% | -$76.3K |
|
|
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
| $613K | 1% |
31,945
-3,355
| -10% | -$64.4K |
|
29
Applied Materials
AMAT
$125B
| $577K | 0.94% |
+27,236
| New | +$577K |
|
|
AERI
30
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $572K | 0.93% |
47,065
-2,491
| -5% | -$30.3K |
|
|
TFCFA
31
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $546K | 0.89% |
+19,595
| New | +$546K |
|
|
ZLTQ
32
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $542K | 0.88% |
19,974
+8,302
| +71% | +$225K |
|
33
Herbalife
HLF
$1.01B
| $520K | 0.85% |
+8,453
| New | +$520K |
|
34
Charter Communications
CHTR
$36B
| $501K | 0.82% |
2,473
+39
| +2% | +$7.9K |
|
35
Becton Dickinson
BDX
$54.3B
| $468K | 0.76% |
+3,082
| New | +$468K |
|
36
Accuray
ARAY
$155M
| $456K | 0.74% |
78,883
-504
| -0.6% | -$2.91K |
|
37
Salesforce
CRM
$239B
| $449K | 0.73% |
+6,080
| New | +$449K |
|
38
Innoviva
INVA
$1.31B
| $428K | 0.7% |
33,973
-17,414
| -34% | -$219K |
|
|
RAD
39
DELISTED
Rite Aid Corporation
RAD
| $403K | 0.66% |
49,411
-327
| -0.7% | -$2.67K |
|
40
Trip.com Group
TCOM
$46.4B
| $373K | 0.61% |
+8,431
| New | +$373K |
|
|
BPMC
41
DELISTED
Blueprint Medicines
BPMC
| $339K | 0.55% |
18,788
+736
| +4% | +$13.3K |
|
|
AET
42
DELISTED
Aetna Inc
AET
| $336K | 0.55% |
2,991
-8,084
| -73% | -$908K |
|
43
DaVita
DVA
$9.71B
| $333K | 0.54% |
+4,544
| New | +$333K |
|
44
iShares Biotechnology ETF
IBB
$5.65B
| $327K | 0.53% |
+1,255
| New | +$327K |
|
45
Hologic
HOLX
$14.8B
| $317K | 0.52% |
9,194
-16,294
| -64% | -$562K |
|
|
ACOR
46
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $296K | 0.48% |
11,190
-16,742
| -60% | -$443K |
|
|
GBT
47
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $267K | 0.43% |
16,848
+1,214
| +8% | +$19.2K |
|
|
HDP
48
DELISTED
Hortonworks, Inc.
HDP
| $260K | 0.42% |
23,010
+4,440
| +24% | +$50.2K |
|
49
DexCom
DXCM
$29.2B
| $258K | 0.42% |
3,798
-398
| -9% | -$27K |
|
|
KITE
50
DELISTED
Kite Pharma, Inc.
KITE
| $254K | 0.41% |
5,542
-3,885
| -41% | -$178K |
|